The Duke Cancer Institute offers treatment options for neuroblastoma not found at many other institutions, including our experienced bone marrow transplant program.
Each patient is thoroughly evaluated by a pediatric oncologist with special expertise in neuroblastoma. Individualized care plans provide each patient with the greatest opportunity to overcome their cancer while maintaining a high quality of life.
The Duke Cancer Institute is one of a few places patients can find a new treatment program using MIBG, a compound that selectively concentrates in neuroblastoma tumor cells, to selectively deliver tumor-killing radioactive iodine.
Depending on the child’s age, cancer stage, and location of the tumor, treatment may include a combination of:
The patient care team helps coordinate appointments with other specialists within the Duke Cancer Institute as necessary.
Duke is one of only 14 medical centers nationwide that are part of the New Approaches to Neuroblastoma Treatment (NANT) Consortium. This affiliation, as well as our participation in the Children’s Oncology Group provides patients with access to treatments not available at most medical centers through clinical trials.
Learn how to make an appointment at the Duke Cancer Institute.